Cargando…
Molecular subtyping reveals uniqueness of prognosis in breast ductal carcinoma in situ patients with lumpectomy
BACKGROUND: We aimed to analyse the discrepancy in clinical features and prognosis between molecular subtypes in primary ductal carcinoma in situ (DCIS) patients with lumpectomy. METHODS: Primary DCIS patients were identified from the Surveillance, Epidemiology, and End Results registries database f...
Autores principales: | Yang, Libo, Shen, Mengjia, Qiu, Yan, Tang, Tingting, Bu, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039875/ https://www.ncbi.nlm.nih.gov/pubmed/35462343 http://dx.doi.org/10.1016/j.breast.2022.03.019 |
Ejemplares similares
-
Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy
por: Giannakeas, Vasily, et al.
Publicado: (2018) -
Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study
por: Zhou, Wenjing, et al.
Publicado: (2013) -
Redefining Lumpectomy Using a Modification of the “Sick Lobe” Hypothesis and Ductal Anatomy
por: Dooley, W., et al.
Publicado: (2011) -
Ductal Carcinoma In Situ of the Breast: Perspectives on Tumor Subtype and Treatment
por: Liu, Yufei, et al.
Publicado: (2020) -
Molecular subtypes predict second breast events of ductal carcinoma in situ after breast‐conserving surgery
por: Yang, Yilan, et al.
Publicado: (2022)